4D Molecular Therapeutics FDMT

$ 9.09 2.48%

Annual report 2025
added 03-18-2026

Country	USA
IPO year	2020
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	57.9 M
Market Cap^[1]	$ 527 M
EBITDA (LTM)	$ -221 M
P/E (LTM)	-2.44
P/S (LTM)	4211.81
EPS (LTM)	-3.64

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.